Literature DB >> 7491512

Psychopathology and mortality in the general population.

A Kouzis1, W W Eaton, P J Leaf.   

Abstract

Community studies of the relationship between mortality and mental disorders remain equivocal with mixed and unclear results. Longitudinal prospective data from the Epidemiologic Catchment Area Program are examined for the relationship between psychopathology and mortality. Analyses were performed with mortality at 1-year follow-up as the dependent variable using logistic regression. Specifically, the odds of dying from psychiatric disorders were considered while statistically adjusting for sociodemographic characteristics and treatment in primary or specialty medical care sectors. Significant predictors of dying were being male, older, and from low income households. Subjects with drug abuse or dependence were 12.4 times (CI = 2.9, 53.0) as likely to die as those without drug abuse/dependence. The odds of dying for those with major depressive disorder were over 2.6 times (CI = 1.1, 6.0) those without major depression. Separate analyses for all five communities and for only those over the age of 55 years showed similar results.

Entities:  

Mesh:

Year:  1995        PMID: 7491512     DOI: 10.1007/bf00790655

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  43 in total

1.  Sampler of findings from the 1986 national mortality followback survey on risk factors, disability, and health care.

Authors:  I Seeman
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

2.  The course, morbidity, and costs of depression.

Authors:  G L Klerman; M M Weissman
Journal:  Arch Gen Psychiatry       Date:  1992-10

3.  Depressive disorders. Further evidence for increased medical morbidity and impairment of social functioning.

Authors:  G L Klerman
Journal:  Arch Gen Psychiatry       Date:  1989-09

4.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

5.  Moderate drinking and coronary heart disease mortality: evidence from NHANES I and the NHANES I Follow-up.

Authors:  D Coate
Journal:  Am J Public Health       Date:  1993-06       Impact factor: 9.308

6.  Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study.

Authors:  M L Bruce; P J Leaf; G P Rozal; L Florio; R A Hoff
Journal:  Am J Psychiatry       Date:  1994-05       Impact factor: 18.112

7.  The Iowa record-linkage study. II. Excess mortality among patients with organic mental disorders.

Authors:  D W Black; G Warrack; G Winokur
Journal:  Arch Gen Psychiatry       Date:  1985-01

8.  The Iowa record-linkage study. I. Suicides and accidental deaths among psychiatric patients.

Authors:  D W Black; G Warrack; G Winokur
Journal:  Arch Gen Psychiatry       Date:  1985-01

9.  The Iowa record-linkage study. III. Excess mortality among patients with 'functional' disorders.

Authors:  D W Black; G Warrack; G Winokur
Journal:  Arch Gen Psychiatry       Date:  1985-01

10.  Alcohol and cardiovascular disease: the status of the U shaped curve.

Authors:  M Marmot; E Brunner
Journal:  BMJ       Date:  1991-09-07
View more
  23 in total

Review 1.  The burden of mental disorders.

Authors:  William W Eaton; Silvia S Martins; Gerald Nestadt; O Joseph Bienvenu; Diana Clarke; Pierre Alexandre
Journal:  Epidemiol Rev       Date:  2008-09-19       Impact factor: 6.222

2.  Depressive behavior and coronary artery atherogenesis in adult female cynomolgus monkeys.

Authors:  Carol A Shively; Thomas C Register; Michael R Adams; Debbie L Golden; Stephanie L Willard; Thomas B Clarkson
Journal:  Psychosom Med       Date:  2008-07-02       Impact factor: 4.312

3.  Examining variation in depressive symptoms over the life course: a latent class analysis.

Authors:  B Mezuk; K S Kendler
Journal:  Psychol Med       Date:  2012-02-24       Impact factor: 7.723

Review 4.  Behavioral and neurobiological characteristics of social stress versus depression in nonhuman primates.

Authors:  Carol A Shively; Stephanie L Willard
Journal:  Exp Neurol       Date:  2011-09-24       Impact factor: 5.330

5.  Effects of long-term sertraline treatment and depression on coronary artery atherosclerosis in premenopausal female primates.

Authors:  Carol A Shively; Thomas C Register; Susan E Appt; Thomas B Clarkson
Journal:  Psychosom Med       Date:  2015-04       Impact factor: 4.312

6.  Time trends in mortality associated with depression: findings from the Stirling County study.

Authors:  Jane M Murphy; Stephen E Gilman; Alain Lesage; Nicholas J Horton; Daniel Rasic; Nhi-Ha Trinh; Bibi Alamiri; Arthur M Sobol; Maurizio Fava; Jordan W Smoller
Journal:  Can J Psychiatry       Date:  2010-12       Impact factor: 4.356

7.  Psychosocial aetiology of chronic disease: a pragmatic approach to the assessment of lifetime affective morbidity in an EPIC component study.

Authors:  P G Surtees; N W Wainwright; C Brayne
Journal:  J Epidemiol Community Health       Date:  2000-02       Impact factor: 3.710

8.  The relationship of mental and behavioral disorders to all-cause mortality in a 27-year follow-up of 4 epidemiologic catchment area samples.

Authors:  William W Eaton; Kimberly B Roth; Martha Bruce; Linda Cottler; Litzy Wu; Gerald Nestadt; Dan Ford; O Joseph Bienvenu; Rosa M Crum; George Rebok; James C Anthony; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2013-10-03       Impact factor: 4.897

9.  Differences in the indicators of depressive symptoms among a community sample of African-American and Caucasian older adults.

Authors:  Terry L Mills; Nicole L Alea; Josepha A Cheong
Journal:  Community Ment Health J       Date:  2004-08

Review 10.  Stress, depression, and coronary artery disease: modeling comorbidity in female primates.

Authors:  Carol A Shively; Dominique L Musselman; Stephanie L Willard
Journal:  Neurosci Biobehav Rev       Date:  2008-06-24       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.